A bill that would effectively force dozens of biopharma companies to cut ties with WuXi AppTec and four other Chinese biotech ...

Galapagos is teaming up with the US’s largest blood supply group to try to establish a nationwide network of decentralized ...

GoodRx said on Wednesday that it has won back its relationship with Kroger to offer prescription discount coupons to people ...

Eli Lil­ly reached a set­tle­ment with a South Car­oli­na med­ical spa, mark­ing a win in a broad­er le­gal cam­paign against ...

Less than a year af­ter the end of a PD-1 deal with No­var­tis, BeiGene is look­ing at new part­ner­ships that could bring in ...

The World Health Or­ga­ni­za­tion pre­qual­i­fied Take­da’s new dengue vac­cine on Wednes­day, a year af­ter the com­pa­ny ...

The cardiovascular benefits of Novo Nordisk’s blockbuster weight loss drug Wegovy are not dependent on the amount of weight ...

Merck KGaA’s revenue from its CDMO arm dropped in the first quarter due to customer destocking, but it still expects business ...

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) Elec­tron­ics gi­ant LG on ...

The In­sti­tute for Clin­i­cal and Eco­nom­ic Re­view said it can­not fair­ly judge Lykos Ther­a­peu­tics’ MD­MA-as­sist­ed ...

Eisai is hoping to grow Leqembi sales 13-fold to around $360 million in fiscal year 2024, as it plans “aggressive investment” and looks to expand its Biogen-partnered Alzheimer’s drug’s market both in ...

Less than a month after revealing pipeline cuts amid disappointing gene therapy sales, BioMarin is now also downsizing its team. The biotech said it will lay off about 170 workers worldwide on the ...